カテゴリー： 世界, 医療/バイオ, GlobalInfoResearch

世界のヒト水痘・帯状疱疹免疫グロブリン市場2023年：企業・地域・タイプ・用途別分析

【英語タイトル】Global Human Varicella-Zoster Immunoglobulin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが出版した調査資料（GIR23SM7884）・商品コード：GIR23SM7884
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2023年9月
・ページ数：93
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（注文後2-3日）
・調査対象地域：グローバル
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界のヒト水痘・帯状疱疹免疫グロブリンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のヒト水痘・帯状疱疹免疫グロブリン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- ヒト水痘・帯状疱疹免疫グロブリンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

ヒト水痘・帯状疱疹免疫グロブリン市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・フリーズドライ粉末、注射剤

用途別セグメント
・病院、診療所

主要な市場プレーヤー
・Bio Products Laboratory、MassBiologics、Saol Therapeutics、Aptevo Biotherapeutics Llc、Ki Biopharma Llc、Cangene Biopharma、Kamada、Salmedon

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ヒト水痘・帯状疱疹免疫グロブリン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヒト水痘・帯状疱疹免疫グロブリンメーカーの企業概要、2019年～2022年までのヒト水痘・帯状疱疹免疫グロブリンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヒト水痘・帯状疱疹免疫グロブリンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ヒト水痘・帯状疱疹免疫グロブリンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのヒト水痘・帯状疱疹免疫グロブリンのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのヒト水痘・帯状疱疹免疫グロブリン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびヒト水痘・帯状疱疹免疫グロブリンの産業チェーンを掲載しています。
・第14、15章では、ヒト水痘・帯状疱疹免疫グロブリンの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– ヒト水痘・帯状疱疹免疫グロブリンの概要
– タイプ別分析（2018年vs2022年vs2029年）：フリーズドライ粉末、注射剤
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所
– 世界のヒト水痘・帯状疱疹免疫グロブリン市場規模・予測
– 世界のヒト水痘・帯状疱疹免疫グロブリン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Bio Products Laboratory、MassBiologics、Saol Therapeutics、Aptevo Biotherapeutics Llc、Ki Biopharma Llc、Cangene Biopharma、Kamada、Salmedon
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：フリーズドライ粉末、注射剤
・用途別分析2018年-2029年：病院、診療所
・ヒト水痘・帯状疱疹免疫グロブリンの北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ヒト水痘・帯状疱疹免疫グロブリンのヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ヒト水痘・帯状疱疹免疫グロブリンのアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ヒト水痘・帯状疱疹免疫グロブリンの南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ヒト水痘・帯状疱疹免疫グロブリンの中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Human Varicella-Zoster Immunoglobulin
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Varicella-Zoster Immunoglobulin Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Freeze-dried Powder
1.3.3 Injection
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Varicella-Zoster Immunoglobulin Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Human Varicella-Zoster Immunoglobulin Market Size & Forecast
1.5.1 Global Human Varicella-Zoster Immunoglobulin Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human Varicella-Zoster Immunoglobulin Sales Quantity (2018-2029)
1.5.3 Global Human Varicella-Zoster Immunoglobulin Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Bio Products Laboratory
2.1.1 Bio Products Laboratory Details
2.1.2 Bio Products Laboratory Major Business
2.1.3 Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Product and Services
2.1.4 Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bio Products Laboratory Recent Developments/Updates
2.2 MassBiologics
2.2.1 MassBiologics Details
2.2.2 MassBiologics Major Business
2.2.3 MassBiologics Human Varicella-Zoster Immunoglobulin Product and Services
2.2.4 MassBiologics Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 MassBiologics Recent Developments/Updates
2.3 Saol Therapeutics
2.3.1 Saol Therapeutics Details
2.3.2 Saol Therapeutics Major Business
2.3.3 Saol Therapeutics Human Varicella-Zoster Immunoglobulin Product and Services
2.3.4 Saol Therapeutics Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Saol Therapeutics Recent Developments/Updates
2.4 Aptevo Biotherapeutics Llc
2.4.1 Aptevo Biotherapeutics Llc Details
2.4.2 Aptevo Biotherapeutics Llc Major Business
2.4.3 Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Product and Services
2.4.4 Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Aptevo Biotherapeutics Llc Recent Developments/Updates
2.5 Ki Biopharma Llc
2.5.1 Ki Biopharma Llc Details
2.5.2 Ki Biopharma Llc Major Business
2.5.3 Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Product and Services
2.5.4 Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Ki Biopharma Llc Recent Developments/Updates
2.6 Cangene Biopharma
2.6.1 Cangene Biopharma Details
2.6.2 Cangene Biopharma Major Business
2.6.3 Cangene Biopharma Human Varicella-Zoster Immunoglobulin Product and Services
2.6.4 Cangene Biopharma Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cangene Biopharma Recent Developments/Updates
2.7 Kamada
2.7.1 Kamada Details
2.7.2 Kamada Major Business
2.7.3 Kamada Human Varicella-Zoster Immunoglobulin Product and Services
2.7.4 Kamada Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Kamada Recent Developments/Updates
2.8 Salmedon
2.8.1 Salmedon Details
2.8.2 Salmedon Major Business
2.8.3 Salmedon Human Varicella-Zoster Immunoglobulin Product and Services
2.8.4 Salmedon Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Salmedon Recent Developments/Updates
3 Competitive Environment: Human Varicella-Zoster Immunoglobulin by Manufacturer
3.1 Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human Varicella-Zoster Immunoglobulin Revenue by Manufacturer (2018-2023)
3.3 Global Human Varicella-Zoster Immunoglobulin Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human Varicella-Zoster Immunoglobulin by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human Varicella-Zoster Immunoglobulin Manufacturer Market Share in 2022
3.4.2 Top 6 Human Varicella-Zoster Immunoglobulin Manufacturer Market Share in 2022
3.5 Human Varicella-Zoster Immunoglobulin Market: Overall Company Footprint Analysis
3.5.1 Human Varicella-Zoster Immunoglobulin Market: Region Footprint
3.5.2 Human Varicella-Zoster Immunoglobulin Market: Company Product Type Footprint
3.5.3 Human Varicella-Zoster Immunoglobulin Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Human Varicella-Zoster Immunoglobulin Market Size by Region
4.1.1 Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Region (2018-2029)
4.1.2 Global Human Varicella-Zoster Immunoglobulin Consumption Value by Region (2018-2029)
4.1.3 Global Human Varicella-Zoster Immunoglobulin Average Price by Region (2018-2029)
4.2 North America Human Varicella-Zoster Immunoglobulin Consumption Value (2018-2029)
4.3 Europe Human Varicella-Zoster Immunoglobulin Consumption Value (2018-2029)
4.4 Asia-Pacific Human Varicella-Zoster Immunoglobulin Consumption Value (2018-2029)
4.5 South America Human Varicella-Zoster Immunoglobulin Consumption Value (2018-2029)
4.6 Middle East and Africa Human Varicella-Zoster Immunoglobulin Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2018-2029)
5.2 Global Human Varicella-Zoster Immunoglobulin Consumption Value by Type (2018-2029)
5.3 Global Human Varicella-Zoster Immunoglobulin Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2018-2029)
6.2 Global Human Varicella-Zoster Immunoglobulin Consumption Value by Application (2018-2029)
6.3 Global Human Varicella-Zoster Immunoglobulin Average Price by Application (2018-2029)
7 North America
7.1 North America Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2018-2029)
7.2 North America Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2018-2029)
7.3 North America Human Varicella-Zoster Immunoglobulin Market Size by Country
7.3.1 North America Human Varicella-Zoster Immunoglobulin Sales Quantity by Country (2018-2029)
7.3.2 North America Human Varicella-Zoster Immunoglobulin Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2018-2029)
8.2 Europe Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2018-2029)
8.3 Europe Human Varicella-Zoster Immunoglobulin Market Size by Country
8.3.1 Europe Human Varicella-Zoster Immunoglobulin Sales Quantity by Country (2018-2029)
8.3.2 Europe Human Varicella-Zoster Immunoglobulin Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Human Varicella-Zoster Immunoglobulin Market Size by Region
9.3.1 Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human Varicella-Zoster Immunoglobulin Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2018-2029)
10.2 South America Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2018-2029)
10.3 South America Human Varicella-Zoster Immunoglobulin Market Size by Country
10.3.1 South America Human Varicella-Zoster Immunoglobulin Sales Quantity by Country (2018-2029)
10.3.2 South America Human Varicella-Zoster Immunoglobulin Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Human Varicella-Zoster Immunoglobulin Market Size by Country
11.3.1 Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human Varicella-Zoster Immunoglobulin Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Human Varicella-Zoster Immunoglobulin Market Drivers
12.2 Human Varicella-Zoster Immunoglobulin Market Restraints
12.3 Human Varicella-Zoster Immunoglobulin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Human Varicella-Zoster Immunoglobulin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Varicella-Zoster Immunoglobulin
13.3 Human Varicella-Zoster Immunoglobulin Production Process
13.4 Human Varicella-Zoster Immunoglobulin Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Varicella-Zoster Immunoglobulin Typical Distributors
14.3 Human Varicella-Zoster Immunoglobulin Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Human Varicella-Zoster Immunoglobulin Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Human Varicella-Zoster Immunoglobulin Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bio Products Laboratory Basic Information, Manufacturing Base and Competitors
Table 4. Bio Products Laboratory Major Business
Table 5. Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Product and Services
Table 6. Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bio Products Laboratory Recent Developments/Updates
Table 8. MassBiologics Basic Information, Manufacturing Base and Competitors
Table 9. MassBiologics Major Business
Table 10. MassBiologics Human Varicella-Zoster Immunoglobulin Product and Services
Table 11. MassBiologics Human Varicella-Zoster Immunoglobulin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. MassBiologics Recent Developments/Updates
Table 13. Saol Therapeutics Basic Information, Manufacturing Base and Competitors
Table 14. Saol Therapeutics Major Business
Table 15. Saol Therapeutics Human Varicella-Zoster Immunoglobulin Product and Services
Table 16. Saol Therapeutics Human Varicella-Zoster Immunoglobulin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Saol Therapeutics Recent Developments/Updates
Table 18. Aptevo Biotherapeutics Llc Basic Information, Manufacturing Base and Competitors
Table 19. Aptevo Biotherapeutics Llc Major Business
Table 20. Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Product and Services
Table 21. Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Aptevo Biotherapeutics Llc Recent Developments/Updates
Table 23. Ki Biopharma Llc Basic Information, Manufacturing Base and Competitors
Table 24. Ki Biopharma Llc Major Business
Table 25. Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Product and Services
Table 26. Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Ki Biopharma Llc Recent Developments/Updates
Table 28. Cangene Biopharma Basic Information, Manufacturing Base and Competitors
Table 29. Cangene Biopharma Major Business
Table 30. Cangene Biopharma Human Varicella-Zoster Immunoglobulin Product and Services
Table 31. Cangene Biopharma Human Varicella-Zoster Immunoglobulin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Cangene Biopharma Recent Developments/Updates
Table 33. Kamada Basic Information, Manufacturing Base and Competitors
Table 34. Kamada Major Business
Table 35. Kamada Human Varicella-Zoster Immunoglobulin Product and Services
Table 36. Kamada Human Varicella-Zoster Immunoglobulin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Kamada Recent Developments/Updates
Table 38. Salmedon Basic Information, Manufacturing Base and Competitors
Table 39. Salmedon Major Business
Table 40. Salmedon Human Varicella-Zoster Immunoglobulin Product and Services
Table 41. Salmedon Human Varicella-Zoster Immunoglobulin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Salmedon Recent Developments/Updates
Table 43. Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 44. Global Human Varicella-Zoster Immunoglobulin Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Human Varicella-Zoster Immunoglobulin Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 46. Market Position of Manufacturers in Human Varicella-Zoster Immunoglobulin, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Human Varicella-Zoster Immunoglobulin Production Site of Key Manufacturer
Table 48. Human Varicella-Zoster Immunoglobulin Market: Company Product Type Footprint
Table 49. Human Varicella-Zoster Immunoglobulin Market: Company Product Application Footprint
Table 50. Human Varicella-Zoster Immunoglobulin New Market Entrants and Barriers to Market Entry
Table 51. Human Varicella-Zoster Immunoglobulin Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Region (2018-2023) & (K Units)
Table 53. Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Region (2024-2029) & (K Units)
Table 54. Global Human Varicella-Zoster Immunoglobulin Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Human Varicella-Zoster Immunoglobulin Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Human Varicella-Zoster Immunoglobulin Average Price by Region (2018-2023) & (US$/Unit)
Table 57. Global Human Varicella-Zoster Immunoglobulin Average Price by Region (2024-2029) & (US$/Unit)
Table 58. Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Global Human Varicella-Zoster Immunoglobulin Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Human Varicella-Zoster Immunoglobulin Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Human Varicella-Zoster Immunoglobulin Average Price by Type (2018-2023) & (US$/Unit)
Table 63. Global Human Varicella-Zoster Immunoglobulin Average Price by Type (2024-2029) & (US$/Unit)
Table 64. Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2018-2023) & (K Units)
Table 65. Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2024-2029) & (K Units)
Table 66. Global Human Varicella-Zoster Immunoglobulin Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Human Varicella-Zoster Immunoglobulin Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Human Varicella-Zoster Immunoglobulin Average Price by Application (2018-2023) & (US$/Unit)
Table 69. Global Human Varicella-Zoster Immunoglobulin Average Price by Application (2024-2029) & (US$/Unit)
Table 70. North America Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2018-2023) & (K Units)
Table 71. North America Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2024-2029) & (K Units)
Table 72. North America Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2018-2023) & (K Units)
Table 73. North America Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2024-2029) & (K Units)
Table 74. North America Human Varicella-Zoster Immunoglobulin Sales Quantity by Country (2018-2023) & (K Units)
Table 75. North America Human Varicella-Zoster Immunoglobulin Sales Quantity by Country (2024-2029) & (K Units)
Table 76. North America Human Varicella-Zoster Immunoglobulin Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Human Varicella-Zoster Immunoglobulin Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Europe Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Europe Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2018-2023) & (K Units)
Table 81. Europe Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2024-2029) & (K Units)
Table 82. Europe Human Varicella-Zoster Immunoglobulin Sales Quantity by Country (2018-2023) & (K Units)
Table 83. Europe Human Varicella-Zoster Immunoglobulin Sales Quantity by Country (2024-2029) & (K Units)
Table 84. Europe Human Varicella-Zoster Immunoglobulin Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Human Varicella-Zoster Immunoglobulin Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2018-2023) & (K Units)
Table 87. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2024-2029) & (K Units)
Table 88. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2018-2023) & (K Units)
Table 89. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2024-2029) & (K Units)
Table 90. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Quantity by Region (2018-2023) & (K Units)
Table 91. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Quantity by Region (2024-2029) & (K Units)
Table 92. Asia-Pacific Human Varicella-Zoster Immunoglobulin Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Human Varicella-Zoster Immunoglobulin Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2018-2023) & (K Units)
Table 95. South America Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2024-2029) & (K Units)
Table 96. South America Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2018-2023) & (K Units)
Table 97. South America Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2024-2029) & (K Units)
Table 98. South America Human Varicella-Zoster Immunoglobulin Sales Quantity by Country (2018-2023) & (K Units)
Table 99. South America Human Varicella-Zoster Immunoglobulin Sales Quantity by Country (2024-2029) & (K Units)
Table 100. South America Human Varicella-Zoster Immunoglobulin Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Human Varicella-Zoster Immunoglobulin Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2018-2023) & (K Units)
Table 103. Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2024-2029) & (K Units)
Table 104. Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Quantity by Region (2018-2023) & (K Units)
Table 107. Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Quantity by Region (2024-2029) & (K Units)
Table 108. Middle East & Africa Human Varicella-Zoster Immunoglobulin Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Human Varicella-Zoster Immunoglobulin Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Human Varicella-Zoster Immunoglobulin Raw Material
Table 111. Key Manufacturers of Human Varicella-Zoster Immunoglobulin Raw Materials
Table 112. Human Varicella-Zoster Immunoglobulin Typical Distributors
Table 113. Human Varicella-Zoster Immunoglobulin Typical Customers
List of Figures
Figure 1. Human Varicella-Zoster Immunoglobulin Picture
Figure 2. Global Human Varicella-Zoster Immunoglobulin Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Human Varicella-Zoster Immunoglobulin Consumption Value Market Share by Type in 2022
Figure 4. Freeze-dried Powder Examples
Figure 5. Injection Examples
Figure 6. Global Human Varicella-Zoster Immunoglobulin Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Human Varicella-Zoster Immunoglobulin Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Human Varicella-Zoster Immunoglobulin Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Human Varicella-Zoster Immunoglobulin Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Human Varicella-Zoster Immunoglobulin Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Human Varicella-Zoster Immunoglobulin Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Human Varicella-Zoster Immunoglobulin Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Human Varicella-Zoster Immunoglobulin by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Human Varicella-Zoster Immunoglobulin Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Human Varicella-Zoster Immunoglobulin Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Human Varicella-Zoster Immunoglobulin Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Human Varicella-Zoster Immunoglobulin Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Human Varicella-Zoster Immunoglobulin Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Human Varicella-Zoster Immunoglobulin Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Human Varicella-Zoster Immunoglobulin Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Human Varicella-Zoster Immunoglobulin Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Human Varicella-Zoster Immunoglobulin Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Human Varicella-Zoster Immunoglobulin Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Human Varicella-Zoster Immunoglobulin Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Human Varicella-Zoster Immunoglobulin Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Human Varicella-Zoster Immunoglobulin Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Human Varicella-Zoster Immunoglobulin Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Human Varicella-Zoster Immunoglobulin Consumption Value Market Share by Region (2018-2029)
Figure 52. China Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Human Varicella-Zoster Immunoglobulin Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Human Varicella-Zoster Immunoglobulin Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Human Varicella-Zoster Immunoglobulin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Human Varicella-Zoster Immunoglobulin Market Drivers
Figure 73. Human Varicella-Zoster Immunoglobulin Market Restraints
Figure 74. Human Varicella-Zoster Immunoglobulin Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Human Varicella-Zoster Immunoglobulin in 2022
Figure 77. Manufacturing Process Analysis of Human Varicella-Zoster Immunoglobulin
Figure 78. Human Varicella-Zoster Immunoglobulin Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source


★調査レポート[世界のヒト水痘・帯状疱疹免疫グロブリン市場2023年：企業・地域・タイプ・用途別分析] (コード：GIR23SM7884)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のヒト水痘・帯状疱疹免疫グロブリン市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の抗D免疫グロブリン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の組換えヒト血清アルブミン市場2023年：企業・地域・タイプ・用途別分析
  • 世界のヒトフィブリンシーラントキット市場2023年：企業・地域・タイプ・用途別分析
  • 世界のヒト血清アルブミン市場2023年：企業・地域・タイプ・用途別分析
  • 世界のヒト線維芽細胞培養液市場2023年：企業・地域・タイプ・用途別分析
  • 世界のヒューマンホメオパシー市場2023年：企業・地域・タイプ・用途別分析
  • 世界の母乳殺菌装置市場2023年：企業・地域・タイプ・用途別分析
  • 世界のヒト第VIII因子濃縮製剤市場2023年：企業・地域・タイプ・用途別分析
  • 世界のヒト毛細管血検体採取用単回使用容器市場2023年：企業・地域・タイプ・用途別分析
  • 世界の人体埋め込み型マイクロチップ市場2023年：企業・地域・タイプ・用途別分析

    • ◆H&Iグローバルリサーチのお客様（例）◆